Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center Where you're treated first, matters. To make an appointment, call (844)-422-9799
(4280)

Connect with us:
www.mskcc.org
https://twitter.com/MSKCancerCenter
www.instagram.com/memorialsloankettering
youtube.com/user/mskcc

Our main campus and inpatient hospital are located on the Upper East Side of Manhattan. We also have outpatient facilities in Commack, Uniondale, and Hauppauge on Long Island, New York; West Harrison in Westchester County, New York; and Basking Ridge, Montvale, and Middletown in New Jersey; as well as several locations in New York City.

04/18/2026

🚨 Bad News for Cancer from the 2026 American Association for Cancer Research Annual Meeting:

Hear from MSK gastrointestinal medical oncologist Dr. Michael Foote, as he shares new research from a small (8-person) phase 2 clinical trial that found half of re**al patients with high HER2 saw their tumors disappear with targeted therapies and chemotherapy, meaning they didn't need surgery or in most cases even radiation.

Read more about the research: https://bit.ly/4sB03CB

**alcancer

A small clinical trial (8-person) at Memorial Sloan Kettering Cancer Center (MSK) is showing promise for people with ear...
04/18/2026

A small clinical trial (8-person) at Memorial Sloan Kettering Cancer Center (MSK) is showing promise for people with early-stage re**al cancer whose tumors are driven by excessive amounts of a protein called HER2 (human epidermal growth factor receptor 2).

The trial, led by MSK gastrointestinal medical oncologists Dr. Michael Foote and Dr. Andrea Cercek, suggests that many of these patients may be successfully treated using targeted therapies to avoid surgery, resulting in fewer side effects and better quality of life during and after treatment.

“These tumors can spread to areas of the body like the brain and bone, where re**al cancer usually doesn’t go,” Dr. Foote says, “so we hypothesize that this patient group may benefit from treatment aimed specifically at HER2.”

Learn more about this research: https://bit.ly/4sB03CB

In the Fall of 2025, while Michael was hanging out with a friend, the topic of men’s health came up. His friend disclose...
04/17/2026

In the Fall of 2025, while Michael was hanging out with a friend, the topic of men’s health came up. His friend disclosed his previous diagnosis of testicular cancer, and the symptoms associated with it.

Not even two weeks later, those symptoms – and pain – set in for Michael. "Health is a conversation men don’t have often enough," says Michael. “But if we hadn’t just talked about it, I might have ignored the discomfort I was experiencing,” he shares.

Michael was soon diagnosed with non-seminoma testicular cancer and began care under MSK urologic surgeon Dr. Joel Sheinfeld and MSK genitourinary medical oncologist Dr. Darren Feldman, who are both part of our MSK Urology team, which is ranked #1 in the nation for urology cancer care by US News & World Report.

Michael had surgery in October and started chemotherapy in December. This past February, Michael rang the bell to mark his fourth and final chemotherapy session.

Michael’s "North Star" to get him through the toughest days: training for Hyrox NYC in June 2026. And he’s not just training for a race, but training for a future where men feel empowered to talk about their health and get checked.

"Sharing my story has given me a sense of purpose I didn't know I was missing,” Michael reflects.

Give a 👏 for Michael in the comments below.

04/16/2026

When a lump on his tongue turned out to be cancerous, Charles, an avid glass blower, worried his life would forever be changed. But thanks to a new treatment approach available only at MSK, he did not need to have most of his tongue removed or endure radiation treatment.

A combination of immunotherapy with chemotherapy and targeted therapy shrunk his tumor by more than 90%, so surgery was minimized. His cancer is now in remission, and his speaking and eating ability has not been impaired.

Charles is just one of many patients with a head or neck cancer who come to MSK for a chance to preserve their ability to eat, swallow, speak, and in Charles’ case, continue his beloved pastime blowing glass, despite a cancer that could threaten all those functions.

Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to pre...
04/15/2026

Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery at American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22, in San Diego, California.

MSK investigators will share significant new findings and participate in high‑impact sessions spanning cancer metastasis, immuno‑oncology, molecular biology and genetics, early‑phase drug development, tumor evolution, computational oncology, and precision medicine.

Learn more: https://bit.ly/4eoktLG

At 43, Reicy Bobadilla was an orthopedic surgeon in the Dominican Republic when a persistent cough caught her colleagues...
04/14/2026

At 43, Reicy Bobadilla was an orthopedic surgeon in the Dominican Republic when a persistent cough caught her colleagues’ attention.

“I’d been coughing for about two weeks, but I didn’t think anything was seriously wrong,” she says. “When they told me I should go for a scan, I made fun of them for overreacting.” A scan led to more tests and, a few weeks later, the shocking diagnosis: It was mesothelioma.

Determined to seek the best care, she traveled to NYC for treatment at MSK. During her first meeting with MSK thoracic surgeon Dr. Prasad Adusumilli and MSK thoracic medical oncologist Dr. Michael Offin, they told her that because she had been diagnosed early, and because she was in excellent physical shape, her cancer was treatable and her prognosis was very good.

Over the next several months, Dr. Bobadilla underwent chemotherapy, surgery, and radiation while traveling between countries and continuing to care for her own patients.

“When the doctors explained the treatment plan, I was confident this was the best option for me,” she says. “It was important to me that all the MSK staff I saw were trained to treat this type of disease.”

Today, more than a year after finishing treatment, her scans show no sign of cancer coming back, and she feels “back to 100%.”

“Cancer is a very difficult disease," she says. “The best thing that can happen to you if you have cancer is the support of your family, as well as a well-equipped hospital with staff who know the disease and make you feel safe, like MSK does.”

To learn more about how MSK treats patients with mesothelioma, visit: https://bit.ly/3Qp6ifr

MSK's inpatient and outpatient occupational therapists (OTs) play a vital role in patients’ lives, supporting them throu...
04/13/2026

MSK's inpatient and outpatient occupational therapists (OTs) play a vital role in patients’ lives, supporting them through treatment, recovery, and life after cancer by helping restore strength and function.

These professionals are uniquely equipped to help patients continue engaging in the activities that matter most to them, despite the physical, mental, and emotional challenges of cancer and its treatment. From supporting everyday tasks at home, school, or work to enhancing overall quality of life, MSK OTs empower patients to rebuild strength and confidence.

Thank you to our talented OTs, who bring compassion and creativity to their work every day, helping restore people to their lives!

04/10/2026

In 2024, Mary-Kate was just weeks away from launching her dream life – living full-time in a van with her husband and their dog – when an aggressive breast cancer diagnosis brought everything to a halt. At 34, her world shifted from open roads to hospital halls.

Today, Mary-Kate is no evidence of disease (NED) and officially back behind the wheel, living the adventure she fought to reclaim. 🚐 ⛰️

04/10/2026

How do you navigate a diagnosis when you're looking forward to big plans in life, not a big diagnosis?

As part of Adolescents and Young Adults (AYA) Cancer Awareness Week, MSK nurse practitioner Emily Long Sarro explains how MSK’s AYA Program supports AYAs (ages 15–39) at all stages in life through services like mental health support, access to clinical trials, and dedicated survivorship follow-up.

Knowing your body and speaking up about changes matters at any age. If you or someone you love is diagnosed, support is available.

Share this video with someone you know and learn more about MSK’s AYA Program here: https://bit.ly/4vbu4eL

In October 2024, shortly after turning 20, and smack in the middle of college midterms, Lily was dealing with persistent...
04/09/2026

In October 2024, shortly after turning 20, and smack in the middle of college midterms, Lily was dealing with persistent and unbearable abdominal pain. After multiples tests, an MRI confirmed she had an 8-centimeter tumor in her colon and she was diagnosed with B cell lymphoma.

From November 2024 through February 2025, under the care of MSK lymphoma specialist Dr. Ariela Noy and team members, Lily underwent a specialized treatment plan and chemotherapy. At MSK, we know that for our younger patients, medicine is only part of the story. That’s why AYA nurse practitioner Emily Long Sarro was by her side during and after treatment, providing the age-specific support and guidance Lily needed to navigate life during treatment.

“One thing about me is that if there is a problem, I want to solve it,” Lily remembers thinking after she received her diagnosis. “And once I discovered the Adolescent and Young Adults (AYA) Lounge at MSK, my stay in the hospital changed incrementally,” says Lily.

The MSK Lounge, part of the MSK AYA Program, is a dedicated space for AYA patients (15-39), which features video games, board games, art supplies and classes, books and resources, and a snack bar. Experts from MSK also lead weekly programming and special events.

“I made friends and we would text when to meet there and it felt like we were not even in the hospital. Everyone is the same age, and we just get it," Lily says. "Every chance we get, we would go to the MSK Lounge."

In December 2025, Lily started feeling symptoms again, but delayed coming back to the hospital for fear of missing out. “I knew my senior year winter break was coming up and we had a family trip planned to Paris, and there was a New Year's Eve party with my friends that I wanted to attend,” she shares. “I didn’t want to miss out on anything.”

Lily finally succumbed to her pain and was readmitted to the hospital in January for three weeks. Thankfully, the pain was not a recurrence of her lymphoma and she is doing well. “Right now, I feel great and I’m just really excited to graduate this May.”

Her advice and learning for other AYA patients: "If you don’t feel well, please go get checked.”

Join MSK experts on Monday, April 13 from 12-1pm at MSK Westchester for the next program in MSK's Insight and Hope Breas...
04/09/2026

Join MSK experts on Monday, April 13 from 12-1pm at MSK Westchester for the next program in MSK's Insight and Hope Breast Cancer Lecture Series: Sexual & Vulvovaginal Health After Breast Cancer: What Older Adults Should Know.

This discussion will focus on ways to support comfort, intimacy, and quality of life after breast cancer. Lunch will be served. To register, please call (914) 367-7787.

When Kevin was diagnosed with nasal cavity cancer at 39, he faced the possibility of losing his nose to surgery. MSK hea...
04/08/2026

When Kevin was diagnosed with nasal cavity cancer at 39, he faced the possibility of losing his nose to surgery.

MSK head and neck surgeon Dr. Jennifer Cracchiolo gave Kevin his family reason to hope by sharing a new treatment at MSK using radiation and chemotherapy that could shrink the tumor enough to make surgery unnecessary. This approach was pioneered by MSK radiation oncologist Dr. Nancy Lee and colleagues.

“It wasn’t experimental or a clinical trial, it was something she showed could be effective against the cancer without me having to lose a huge chunk of my nose,” Kevin says. “To us, it sounded amazing, and we agreed right away."

Read more of Kevin's story and about this treatment: https://bit.ly/4miCLjl

Address

New York, NY

Telephone

+13477989213

Website

Alerts

Be the first to know and let us send you an email when Memorial Sloan Kettering Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Memorial Sloan Kettering Cancer Center:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category